Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 73.25B | 63.12B | 65.08B | 62.67B | 59.14B |
Gross Profit | 18.24B | 13.15B | 12.96B | 15.72B | 15.18B |
EBITDA | 8.68B | 5.85B | 3.83B | 8.21B | 7.95B |
Net Income | 2.58B | 1.17B | -407.00M | 2.49B | 2.56B |
Balance Sheet | |||||
Total Assets | 97.11B | 94.54B | 85.03B | 86.47B | 85.03B |
Cash, Cash Equivalents and Short-Term Investments | 16.75B | 16.13B | 9.13B | 12.22B | 11.60B |
Total Debt | 31.35B | 35.14B | 32.47B | 30.87B | 32.10B |
Total Liabilities | 52.60B | 53.24B | 46.73B | 46.09B | 47.63B |
Stockholders Equity | 38.73B | 36.75B | 34.35B | 36.77B | 34.65B |
Cash Flow | |||||
Free Cash Flow | 5.39B | 4.59B | -2.11B | 2.86B | 557.00M |
Operating Cash Flow | 7.53B | 7.09B | 724.00M | 5.52B | 4.96B |
Investing Cash Flow | -2.14B | -2.01B | -2.88B | -2.70B | -3.80B |
Financing Cash Flow | -5.04B | 1.65B | -1.03B | -2.34B | 255.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥43.37B | 18.42 | 3.43% | 13.35% | 36.31% | ||
78 Outperform | ¥35.36B | 3.77 | 3.94% | 0.79% | 104.86% | ||
74 Outperform | ¥25.30B | 7.75 | 4.41% | 9.75% | 28.00% | ||
73 Outperform | ¥34.69B | 11.75 | 2.72% | -0.44% | 11.34% | ||
72 Outperform | ¥28.85B | 12.10 | 2.03% | 15.27% | 48.08% | ||
69 Neutral | ¥46.08B | 14.63 | 1.00% | 11.99% | 31.00% | ||
62 Neutral | $10.39B | 9.84 | 1.51% | 2.86% | 2.35% | -34.25% |
DKS Co., Ltd. has revised its financial forecasts for the six months ending September 30, 2025, and the fiscal year ending March 31, 2026, reflecting a significant increase in expected profits. This upward revision is driven by strong growth in high-value-added products, despite uncertainties like U.S. tariff measures and exchange rate fluctuations. The company anticipates that profits for both the six-month period and the fiscal year will exceed initial estimates, indicating a positive impact on its operations and market positioning.
DKS Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 8.6% and operating income increasing by 62.8% year-on-year. The company revised its earnings forecast for the fiscal year ending March 31, 2026, indicating positive expectations for future growth, which may enhance its market positioning and stakeholder confidence.
DKS Co., Ltd. has announced the completion of payment procedures for the disposition of treasury stock under its restricted stock compensation plan. This move, resolved at the Board of Directors meeting on June 25, 2025, involves the disposal of 5,901 shares of common stock at a price of 3,810 yen per share, totaling 22,482,810 yen. The allotment is aimed at directors and audit & supervisory board members, reflecting the company’s commitment to aligning executive interests with shareholder value.
DKS Co., Ltd. has announced the disposal of 5,901 shares of its treasury stock under a Restricted Stock Compensation Plan, as resolved by its Board of Directors. This move is part of a broader strategy to align the interests of its directors and supervisory board members with those of its shareholders, facilitating the achievement of targets set in its medium-term management plan, SMART 2030.
DKS Co., Ltd. has announced a proposal to amend its Articles of Incorporation to include agricultural products as part of its business objectives. This strategic move aims to strengthen its Life & Wellness business and promote new business development to address social issues, potentially enhancing its market position and offering new opportunities for stakeholders.
DKS Co., Ltd. reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales rising by 16.1% and operating income surging by 157.6%. This growth reflects the company’s strong market positioning and effective operational strategies, potentially benefiting stakeholders through increased dividends and a positive outlook for the upcoming fiscal year.
DKS Co., Ltd. announced an extraordinary loss due to an impairment loss of ¥365 million on fixed assets held by its subsidiary, IKEDA YAKUSOU Co., Ltd., for the fourth quarter of the fiscal year ending March 31, 2025. This financial adjustment reflects the company’s adherence to the Accounting Standard for Impairment of Fixed Assets, impacting its financial results for the period.